STOCK-BASED COMPENSATION (Tables)
|
3 Months Ended |
Jun. 30, 2026 |
|---|
| Share-Based Payment Arrangement [Abstract] |
|
| Schedule of Performance Shares Vesting Based on EPS Targets |
The 2025 Performance Shares performance target is set forth below.
| | | | | | Trailing 4-Quarter EPS Targets for
July 1, 2025 through March 31, 2027 | Restricted Stock Eligible for Vesting
(Percentage of Award) | | $18.40 | 100% |
|
| Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions |
Fair value was estimated at grant date using the weighted-average assumptions listed below: | | | | | | | | | | | | | Three months ended June 30, | | | | 2026 | | | | | | | | | | | | | | | | Dividend yield | —% | | | | | | | | Expected volatility | 55.09% | | | | | | | | Average risk-free rate | 3.90% | | | | | | | | Expected life | 5.0 years | | | | | | |
|
| Schedule of Stock Option Activity |
Option activity for the three months ended June 30, 2026 was as follows: | | | | | | | | | | | | | | | | | | | | | | | | | Shares | | Weighted Average Exercise
Price | | Weighted Average
Remaining
Contractual Term | | Aggregate Intrinsic Value | | | | | | | | | | Options outstanding, beginning of period | 134,809 | | | $ | 112.92 | | | | | | | Granted during period | 32,675 | | | 134.55 | | | | | | | Exercised during period | (30,389) | | | 108.56 | | | | | | | | | | | | | | | | | | | | | | | Options outstanding, end of period | 137,095 | 3 | | $ | 119.04 | | | 5.9 years | | $ | 14,366,577 | | | Options exercisable, end of period | 82,383 | | | $ | 114.14 | | | 3.6 years | | $ | 9,036,930 | |
|
| Schedule of Intrinsic Value of Options Exercised |
The total intrinsic value and tax benefit of options exercised during the three month periods ended June 30, 2026 and 2025 were as follows: | | | | | | | | | | | | | | | | | Three months ended June 30, | | | | 2026 | | 2025 | | | | | | | | | | | | | | Intrinsic value of options exercised | $ | 2,336,694 | | | $ | 1,000,598 | | | | | | | Tax benefit of options exercised | 572,491 | | | 245,147 | | | | | | | | | | | | | |
|
| Schedule of the Status and Changes Restricted Stock |
A summary of the status of the Company’s restricted stock as of June 30, 2026, and changes during the three months ended June 30, 2026, are presented below: | | | | | | | | | | | | | Shares | | Weighted Average Fair Value at Grant Date | | | | | | Outstanding at March 31, 2026 | 172,500 | | | $ | 156.65 | | | Granted during the period | 10,845 | | | 138.74 | | | Vested during the period4 | (28,592) | | | 157.44 | | | Forfeited during the period5 | (14,503) | | | 150.24 | | | Outstanding at June 30, 2026 | 140,250 | | | $ | 155.77 | |
|
| Schedule of Share-Based Compensation Included as a Component of Net Income (Loss) |
Total stock-based compensation included as a component of personnel expenses in the Company's Consolidated Statements of Operations during the three month periods ended June 30, 2026 and 2025 was as follows:
| | | | | | | | | | | | | | | | | Three months ended June 30, | | | | 2026 | | 2025 | | | | | | Stock-based compensation related to equity classified awards: | | | | | | | | | Stock-based compensation related to stock options | $ | 353,673 | | | $ | 275,881 | | | | | | | Stock-based compensation related to restricted stock | 4,855,227 | | | 2,830,826 | | | | | | | Total stock-based compensation related to equity classified awards | $ | 5,208,900 | | | $ | 3,106,707 | | | | | |
|